戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1         A similar pattern occurred following nasal administration.
2 vivo studies showed mucosal absorption after nasal administration.
3 ung epithelial cells in vivo following intra-nasal administration.
4  induced in DBA/1 mice was studied after the nasal administration (before disease induction) of 1 of
5  variants, exhibits mucosal persistence upon nasal administration, demonstrates enhanced stability co
6 ior of the smart polymers found suitable for nasal administration, including poloxamer, chitosan, EHE
7        No drug CSF uptake was detected after nasal administration of a DFO water solution.
8                                              Nasal administration of a fully human anti-CD3 monoclona
9                                              Nasal administration of a modulatory APL of the heat-sho
10                   Previously, we showed that nasal administration of a naked cDNA plasmid expressing
11         Our results demonstrate that chronic nasal administration of Abeta peptide can induce an immu
12 e showed that blocking IL-10 concurrent with nasal administration of Ag abolished the disease-suppres
13                                              Nasal administration of alanine 183 did not lead to dete
14                              More important, nasal administration of an adenovirus expressing a compl
15          In the present study, we found that nasal administration of an anti-CD3 monoclonal antibody
16                                              Nasal administration of an APL of Hsp60 180-188 induces
17 t mucosal tolerance in EAG can be induced by nasal administration of an immunodominant peptide from t
18                                              Nasal administration of an oil-in-water nanoemulsion (NE
19                           We have found that nasal administration of anti-CD3 mAb attenuated lupus de
20                                              Nasal administration of antigens is effective in inducin
21 mouse model can be effectively suppressed by nasal administration of cardiac myosin (CM).
22                          Here we report that nasal administration of CD3-specific antibody ameliorate
23                                              Nasal administration of CM effectively reduced the sever
24 responses in the respiratory tract following nasal administration of encapsulated antigens.
25                                              Nasal administration of exogenous Hcrt-1 restored social
26    Collectively, these data suggest that the nasal administration of GAD65 peptides induces a Th2 cel
27            We previously reported that prior nasal administration of highly attenuated Bordetella per
28 tion against recolonization, suggesting that nasal administration of live attenuated Spn could be an
29 ystemic protective immunity, suggesting that nasal administration of live attenuated Streptococcus pn
30                We recently demonstrated that nasal administration of mesenchymal stem cells (MSC) rev
31 rate that tumor immunity can be achieved via nasal administration of mRNA.
32                            Here we show that nasal administration of MSC after cisplatin- or paclitax
33 t mucosal tolerance in EAG can be induced by nasal administration of recombinant rat alpha3(IV)NC1 an
34  tolerance in EAG by examining the effect of nasal administration of recombinant rat alpha3(IV)NC1.
35    Here, we demonstrate that subcutaneous or nasal administration of small-molecule MC activators wit
36                                              Nasal administration of specific autoantigens has been r
37            These effects were not induced by nasal administration of synthetic epitopes of diphtheria
38 holine receptor (TAChR), to demonstrate that nasal administration of synthetic sequences of the TAChR
39                           Thereafter, weekly nasal administration of the antigen was given until the
40  or nasal tissues following a single oral or nasal administration of the bacteria, respectively.
41                                    Moreover, nasal administration of the immunosuppressant drug FTY72
42                 In PFF-seeded A53T mice, the nasal administration of the wtTIDM peptide, NEMO-binding
43 ificantly different from that seen following nasal administration of these vectors to mouse lung (rAA
44 rance in EAG by examining the effects of the nasal administration of this peptide after the onset of
45                  In this study, we show that nasal administration of virus-like particles (VLPs) befo
46                                              Nasal administration of wtTIDM in P301S tau-expressing P
47                      In conclusion, only two nasal administrations of MSC fully reverse CIPN and the
48 hology studies in rats after 5 days repeated nasal administration showed that Solutol HS15 had no tox
49 ovation warranting further investigation for nasal administration to potentially reduce infection and
50                                              Nasal administration to rats of 200 mug DFO encapsulated
51 ed 18-50 years were randomized (1:1:1:1) for nasal administration twice (at a 2-wk interval) with sal
52                                        After nasal administration, virus moved down the olfactory ner
53 te bioavailabilities obtained by DCH and MCD nasal administration were 6% and 15%, respectively.